CT
ENTA icon

Clearstead Trust’s Enanta Pharmaceuticals ENTA Stock Holding History

Clearstead Trust’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.8K Hold
5,064
– – 0.01% 278
2026
Q1 		$64K Hold
5,064
– – 0.01% 290
2025
Q4 		$79.9K Hold
5,064
– – 0.01% 275
2025
Q3 		$60.6K Hold
5,064
– – 0.01% 296
2025
Q2 		$38.3K Hold
5,064
– – 0.01% 341
2025
Q1 		$28K Hold
5,064
– – 0.01% 319
2024
Q4 		$29.1K Hold
5,064
– – 0.01% 295
2024
Q3 		$52.5K Hold
5,064
– – 0.01% 241
2024
Q2 		$65.7K Hold
5,064
– – 0.02% 218
2024
Q1 		$88.4K Hold
5,064
– – 0.02% 197
2023
Q4 		$47.7K Hold
5,064
– – 0.01% 239
2023
Q3 		$56.6K Hold
5,064
– – 0.02% 213
2023
Q2 		$108K Hold
5,064
– – 0.03% 172
2023
Q1 		$205K Hold
5,064
– – 0.07% 124
2022
Q4 		$236K Hold
5,064
– – 0.08% 117
2022
Q3 		$263K Buy
+5,064
New +$296K 0.09% 106

Other funds holding ENTA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Clearstead Trust's ENTA Position: Q2 2026 in Review

Clearstead Trust held its Enanta Pharmaceuticals (ENTA) position steady in Q2 2026 at 5,064 shares worth $73.8K. The position accounts for 0.01% of the portfolio, ranked #278.

Clearstead Trust first reported a position in ENTA in Q3 2022 and has held it in 16 quarters since. The position peaked at $263K in Q3 2022. 123 funds tracked by Wall St. Rank hold ENTA as of Q2 2026.

  • Clearstead Trust held 5,064 shares of Enanta Pharmaceuticals worth $73.8K as of Q2 2026.
  • Clearstead Trust left its Enanta Pharmaceuticals share count unchanged in Q2 2026.
  • Enanta Pharmaceuticals made up 0.01% of Clearstead Trust's portfolio in Q2 2026, its #278 holding.
  • Clearstead Trust first reported a position in Enanta Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
  • Clearstead Trust's Enanta Pharmaceuticals position peaked at $263K in Q3 2022.
  • 123 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2026.

Based on Clearstead Trust's 13F filing for Q2 2026, filed 6 Aug 2026.